ARTICLE | Product Development
Oncolytic duos and Dx
February 29, 2016 8:00 AM UTC
Several companies are looking for therapeutic combinations that change how oncolytic viruses interact with cancer cells.
At least two companies, Oncolys BioPharma Inc. and Oryx GmbH & Co. KG, are investigating co-administering the therapies with HDAC inhibitors...